Fact CheckerSign in

NCT07764042Completed

Effects of Wet Cupping Therapy in Patients With Asthma

Investigation of the Effects of Wet Cupping Therapy on Immune Modulation, Pulmonary Function, and Quality of Life in Patients With Asthma

Source: ClinicalTrials.gov · Last updated 13 Aug 2026

Brief summary (registry, in English)

This study evaluated the effects of wet cupping therapy on immune modulation, pulmonary function, and quality of life in adults with asthma. A total of 52 participants aged 30 to 55 years were allocated to either a control group or a wet cupping therapy group. Participants in the wet cupping therapy group received two sessions of wet cupping therapy, at baseline and one month later. Participants in both groups underwent clinical assessments at baseline and at two months. Pulmonary function, asthma-related quality of life, asthma control, dyspnea, fatigue, anxiety, and depression were assessed in both groups. Selected inflammatory markers were assessed only in the wet cupping therapy group.

Status (registry)
Completed
Study type
Interventional
Enrollment
52 (actual)
First submitted
9 Aug 2026
Start date
19 May 2025
Primary completion date
13 Jan 2026
Lead sponsor
Medipol University
Diseases
Asthma
NCT number
NCT07764042

What you commit to

  • Study type: Interventional
  • Participants enrolled: 52
  • From 19 May 2025 to the primary completion date, 13 Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Presence of another chronic disease.

Other

  • Hospitalization during the study period.

Who the study is looking for

  • Adults aged 30 to 55 years.
  • Clinically diagnosed with asthma.
  • Asthma diagnosis established at least 6 months before enrollment.
  • No wet cupping therapy within the previous 2 months.
  • No herbal supplementation affecting asthma within the previous 2 months.
  • Able to cooperate with spirometry testing.

Age in the registry: 30 years to 55 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Medipol Mega University Hospital
Coordinator of this site? Confirm its status
IstanbulTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.